Hematologic Malignancy
Nodular Sclerosis Classic Hodgkin Lymphoma
CI-CAN-00006130NSCHL · NSHD · NSHLExplore in graph →
Hematologic
- NCIt
- C3518
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00006130NSCHL · NSHD · NSHLExplore in graph →
Clinical trials
11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00112723 | Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma | terminated | Phase 1 / Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Aug 8, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Aug 8, 2016source: clinicaltrials